Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Reference237 articles.
1. Parish T. Steps to address anti-microbial drug resistance in today’s drug discovery. Expert Opin Drug Dis. 2019;14:91–4. https://doi.org/10.1080/17460441.2019.1550481.
2. WHO. Prioritization of pathogens to guide discovery, research, and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. 2017; WHO/ EMP/IAU/201712 2017.
3. WHO. Global tuberculosis report 2020. 2020. https://www.who.int/publications/i/item/9789240013131.
4. Dartois VA, Rubin EJ. Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol. 2022;20:685–701. https://doi.org/10.1038/s41579-022-00731-y.
5. Dean AS, Auguet OT, Glaziou P, Zignol M, Ismail N, Kasaeva T, et al. 25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward. Lancet Infect Dis. 2022;22:191–6. https://doi.org/10.1016/S1473-3099(21)00808-2.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献